Synteract

[On Demand]
Search General Info
Search Education
Search Partnering Companies
Synteract®, a Syneos Health® company, is a leading full-service CRO focused on the emerging biopharma segment. The Company's multidisciplinary teams support biotech and pharmaceutical companies across all phases of drug development, providing deep expertise in oncology, dermatology, general medicine, infectious disease and vaccines, neuroscience, pediatrics, and rare and orphan diseases. Synteract has conducted nearly 4,000 studies on six continents in over 62 countries.
Ticker:
SYNH
Exchange:
NASDAQ
Company Type:
Publicly Traded Company
Company Website:
Company HQ State:
North Carolina
Company HQ Country:
United States
Year Founded:
Not Provided
Main Therapeutic Focus:
Lead Product in Development:
CRO for Emerging Biotech
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
Associate Director, Marketing
Synteract, Inc.